Neurology 2002;59:277-279
© 2002 American Academy of Neurology
Brief Communications
C455R notch3 mutation in a Colombian CADASIL kindred with early onset of stroke
J. F. Arboleda–Velasquez, MD*;,
F. Lopera, MD*;,
E. Lopez, MSc,
M. P. Frosch, MD PhD,
D. Sepulveda–Falla,
J. E. Gutierrez, MD,
S. Vargas, MD,
M. Medina, PhD,
C. Martinez de Arrieta, PhD,
R. V. Lebo, PhD,
S. A. Slaugenhaupt, PhD,
R. A. Betensky, PhD,
A. Villegas, MD MSc,
M. Arcos–Burgos, MD PhD,
D. Rivera,
J. C. Restrepo and
K. S. Kosik, MD
*These authors contributed equally to this research.
From the Center for Neurological Diseases (Drs. Arboleda–Velasquez, Medina, Martinez de Arrieta, and Villegas), Brigham and Women’s Hospital–Harvard Medical School; Pathology Department (Dr. Frosch) and Neurology Department (Dr. Slaugenhaupt), Massachusetts General Hospital–Harvard Medical School; Department of Biostatistics (Dr. Betensky), Harvard School of Public Health, Boston, MA; Wilson Laboratory (Dr. Lebo), George Washington University, Washington, DC; Grupo de Neurociencias de Antioquia (Drs. Lopera, Gutierrez, and Vargas, E. Lopez, D. Sepulveda–Falla, and J. Restrepo), and Grupo de Genetica de Poblaiciones, Mutacarciogenesis y Epidemiologica Genetica (Dr. Arcos–Burgos and D. Rivera), Universidad de Antioquia, Medellin, Colombia.
Address correspondence and reprint requests to Dr. Kenneth Kosik, Harvard Institutes of Medicine, 77 Avenue Louis Pasteur, Boston, MA 02115; e-mail: kosik{at}cnd.bwh.harvard.edu
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is caused by mutations in the notch3 epidermal growth factor–like repeats. A Colombian kindred carries a novel C455R mutation located in the predicted ligand-binding domain. Stroke occurred in the patients at an unusually early age (median age: 31 years) in comparison to the more frequent onset in the fourth decade of life in other CADASIL populations, including a second Colombian kindred with an R1031C mutation.
This article has been cited by other articles:
|
|
|
|
 
M. Monet-Lepretre, B. Bardot, B. Lemaire, V. Domenga, O. Godin, M. Dichgans, E. Tournier-Lasserve, M. Cohen-Tannoudji, H. Chabriat, and A. Joutel
Distinct phenotypic and functional features of CADASIL mutations in the Notch3 ligand binding domain
Brain,
June 1, 2009;
132(6):
1601 - 1612.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Mykkanen, M. Junna, K. Amberla, L. Bronge, H. Kaariainen, M. Poyhonen, H. Kalimo, and M. Viitanen
Different Clinical Phenotypes in Monozygotic CADASIL Twins With a Novel NOTCH3 Mutation
Stroke,
June 1, 2009;
40(6):
2215 - 2218.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. D. Brass, E. E. Smith, J. F. Arboleda-Velasquez, W. A. Copen, and M. P. Frosch
Case 12-2009 -- A 46-Year-Old Man with Migraine, Aphasia, and Hemiparesis and Similarly Affected Family Members
N. Engl. J. Med.,
April 16, 2009;
360(16):
1656 - 1665.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. F. Arboleda-Velasquez, R. Rampal, E. Fung, D. C. Darland, M. Liu, M. C. Martinez, C. P. Donahue, M. F. Navarro-Gonzalez, P. Libby, P. A. D'Amore, et al.
CADASIL mutations impair Notch3 glycosylation by Fringe
Hum. Mol. Genet.,
June 15, 2005;
14(12):
1631 - 1639.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Opherk, N. Peters, J. Herzog, R. Luedtke, and M. Dichgans
Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients
Brain,
November 1, 2004;
127(11):
2533 - 2539.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Singhal, S. Bevan, T. Barrick, P. Rich, and H. S. Markus
The influence of genetic and cardiovascular risk factors on the CADASIL phenotype
Brain,
September 1, 2004;
127(9):
2031 - 2038.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
